Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

10x Genomics (TXG) Depreciation & Amortization (CF) (2018 - 2026)

10x Genomics' Depreciation & Amortization (CF) history spans 8 years, with the latest figure at $10.1 million for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 15.03% to $10.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $36.2 million, a 0.89% increase, with the full-year FY2025 number at $36.2 million, up 0.89% from a year prior.
  • Depreciation & Amortization (CF) hit $10.1 million in Q4 2025 for 10x Genomics, down from $10.3 million in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for TXG hit a ceiling of $10.3 million in Q3 2025 and a floor of $4.8 million in Q1 2021.
  • Historically, Depreciation & Amortization (CF) has averaged $7.7 million across 5 years, with a median of $7.9 million in 2025.
  • Biggest five-year swings in Depreciation & Amortization (CF): surged 58.57% in 2021 and later dropped 12.89% in 2025.
  • Tracing TXG's Depreciation & Amortization (CF) over 5 years: stood at $5.8 million in 2021, then rose by 12.8% to $6.5 million in 2022, then surged by 49.01% to $9.7 million in 2023, then fell by 9.95% to $8.8 million in 2024, then increased by 15.03% to $10.1 million in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for TXG at $10.1 million in Q4 2025, $10.3 million in Q3 2025, and $7.8 million in Q2 2025.